Title : Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive value.

Pub. Date : 2009 Sep

PMID : 19641527






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Dasatinib is a highly potent BCR-ABL inhibitor that has shown durable efficacy in patients with chronic phase (CP) chronic myeloid leukemia (CML) after resistance, suboptimal response, or intolerance to prior imatinib. Dasatinib ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens